Table 3 Differential abundance testing for predicted metabolic content and pathways.
From: Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies
BH-adjusted p-values (FDR) | |||||
|---|---|---|---|---|---|
EC 1.8.2 | PWY.5022 | PWY.6470 | GLUTORN.PWY | ARGSYN.PWY | |
Controls vs. EoE baseline | ns | 0.248 | ns | 0.129 | 0.241 |
Controls vs. post-FED | ns | 0.175 | ns | ns | ns |
Controls vs. post-PPI | ns | 0.190 | ns | ns | ns |
Controls vs. post-STC | ns | ns | ns | 0.229 | ns |
Pre-STC vs. post-STC | 0.082 | ns | ns | ns | ns |
Post-STC vs. post-FED | 0.048 | ns | 0.155 | ns | ns |
Post-STC vs. post-PPI | 0.060 | ns | ns | ns | ns |
